Linda Härmark
8PUBLICATIONS
33CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (8)
Sort by Publication Date:
|Aug 25, 2022
Factors Contributing to Best Practices for Patient Involvement in Pharmacovigilance in Europe: A Stakeholder Analysis.Monica van Hoof, Katherine Chinchilla, Linda Härmark
|Dec 24, 2021
Pharmacovigilance Data as a Trigger to Identify Antimicrobial Resistance and Inappropriate Use of Antibiotics: A Study Using Reports from The Netherlands Pharmacovigilance Centre.Jean Marie Vianney Habarugira, Linda Härmark, Albert Figueras
|Aug 09, 2021
Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK.Sieta T de Vries, Petra Denig, Adriana Andrić
|Jul 04, 2020
Correction to: Communicating Adverse Drug Reaction Insights Through Patient Organizations: Experiences from a Pilot Study in the Netherlands.Linda Härmark, Gerda Weits, Rietje Meijer
|Jun 30, 2020
Evaluation of a Web-Based, 'Purchase Event' Intensive Monitoring Method for Pharmacovigilance of Natural Health Products: Lessons and Insights from Development Work in New Zealand.Joanne Barnes, Jane L Sheridan, Christine Yang Dong
Pageof 2
Frequent Collaborators
3 joint publications
Florence van Hunsel
2 joint publications
Gerda Weits
2 joint publications
G Niklas Norén
1 joint publications
Joanne Barnes
1 joint publications
Jane L Sheridan
1 joint publications
Sieta T de Vries
1 joint publications
Petra Denig
1 joint publications
Adriana Andrić
1 joint publications
Peter G M Mol
1 joint publications
Jean Marie Vianney Habarugira